Finance

The Fundamental Case for and Against Cigna Corp (CI)

Cigna Corporation (NYSE:CI) is an interesting stock at present. Now trading with a market value of 44.40B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.

Cigna Corporation (NYSE:CI) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For CI, the company currently has 4.16 billion of cash on the books. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 61.15 billion in total assets, balanced by 46.86 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Cigna Corporation (CI) saw 1.49 billion in free cash flow last quarter, representing a quarterly net change in cash of 970 million. Perhaps most importantly where cash movements are concerned, the company saw about 1.58 billion in net operating cash flow.



Cigna Corporation (NYSE:CI) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 10.4 billion in total revenues. That represents a quarterly year/year change in revenues of 0.05 in sequential terms, the CI saw sales decline by 0.05.

But what about the bottom line? After all, that’s what really matters in the end. Cigna Corporation (CI) is intriguing when broken down to its core data. For shareholders, given the total diluted outstanding shares of 259.77 million, this means overall earnings per share of 2.30. Note, this compares with a consensus analyst forecast of 2.48 in earnings per share for its next fiscal quarterly report.

Is Cigna Corporation (NYSE:CI) Valuation Attractive




Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 11.26 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 15.43. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Cigna Corporation.

Previous ArticleNext Article

Related Post

Aethlon Medical, Inc. (AEMD): Trading Secrets for ... Aethlon Medical, Inc. (NASDAQ:AEMD) gained 35.13% in yesterday’s session, going up from its prior closing price of $2.00 to $2.70, and has now recorde...
How Insiders and Institutions are Trading Teva Pha... Recent insider trends for Teva Pharmaceutical Industries Limited (NYSE:TEVA) have caught the attention of investors. Insider data is useful because it...
Should You Invest in KBR, Inc. (KBR)? A Look at th... Recent insider trends for KBR, Inc. (NYSE:KBR) have caught the attention of investors. Analysts study insider data to get a sense of sense of what key...
Avis Budget Group, Inc. (CAR) Just Flashed an Extr... Avis Budget Group, Inc. (NASDAQ:CAR) fell by -5.15% in Friday’s trading session from $33.80 to $32.06 The stock price went upward in 6 of the last 10 ...
What do Insider Trends Have to Say About Ascent Ca... Recent insider trends for Ascent Capital Group, Inc. (NASDAQ:ASCMA) have caught the attention of investors. Insider activity is often a strong indicat...

Leave a Reply

Your email address will not be published. Required fields are marked *